A pilot study for same-day painless bidirectional endoscopy sedation method

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200056668

Enrollment

Unknown

Registered

2022-02-10

Start date

2022-02-06

Completion date

Unknown

Last updated

2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal screening

Interventions

sedated EGD followed by unsedated colonoscopy:propofol was stopped being administered when the EGD examination finished

edated EGD followed by sedated colonoscopy:propofol was stopped being administered when whole procedure finished

sedated EGD followed by sedated insertion colonoscopy:propofol was stopped being administered when colonoscope inserted into the cecum

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Asymptomatic population aged 35–60 years who schedule for same-day BDE under propofol sedation as part of a routine physical examination.

Exclusion criteria

Exclusion criteria: 1. ASA4 grade and above, propofol allergy, no accompanying or monitoring personnel, contraindication of gastroscopy, polyposis syndrome, colorectal cancer, poor bowel preparation, intestinal obstruction unable to reach blindness, withdrawal events less than 6 minutes, and refusal to participate in the study.

Design outcomes

Primary

Measure	Time frame
patient discomfort;colonoscopy performance;	—

Secondary

Measure	Time frame
total dose of propofol;changes in vital signs;recovery time;discharge time;	—

Countries

China

Contacts

Public ContactSui Yue

Shanxi Medical University

y8515123@163.com+86 18324600502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026